NW CORPORATE RESULTS | Dollar figures in thousands, except per share; parentheses denote losses. Clearwire High-speed wireless Internet...

Share story

Dollar figures in thousands, except per share; parentheses denote losses.

Clearwire
High-speed wireless Internet service
June 30 %
2nd QTR 2008 2007 CHG
Profit ($199,054) ($118,085) -68.6
Per share (1.21) (0.72) -68.1
Sales 58,563 35,484 +65.0
1st HALF 2008 2007 CHG
Profit ($375,443) ($210,720) -78.2
Per share (2.29) (1.37) -67.2
Sales 110,091 64,759 +70.0
COMMENT: Average revenue per user (ARPU) for the Kirkland telecom improved to $39.28 in the second quarter, up $1.35 from the same quarter a year ago. Clearwire had 461,000 subscribers at the end of the quarter, versus 299,000 at the end of the second quarter of 2007; however, the company’s accumulated loss grew to $1.56 billion. Clearwire reaffirmed its previously stated full-year revenue target of $205 million to $215 million, but cut its capital expenditure target to $220 million to $240 million, from $275 million to $290 million.
Eddie Bauer Holdings
Activewear retailer
June 28 June 30 %
2nd QTR 2008 2007 CHG
Profit ($70) ($22,248) +99.7
Per share 0 (0.73) +100
Sales 233,006 226,986 +2.7
1st HALF 2008 2007 CHG
Profit ($19,369) ($67,029) +71.1
Per share (0.63) (2.20) +71.4
Sales 446,250 440,971 +1.2
COMMENT: Bellevue-based Eddie Bauer said the narrowing of its second-quarter loss was driven by increased sales at stores open for at least a year, improved gross margins and lower selling, general and administrative expenses. Same-store sales rose 8.6 percent during the quarter, while sales from the company’s catalogs and Web site decreased 2.1 percent. Gross margin increased $8.3 million from a year ago to $83.6 million. “Sales and profits were up, inventory and SG&A (selling, general and administrative expenses) down,” CEO Neil Fiske said in a statement. “Still, we reiterate that this is a multiyear turnaround effort and that the external environment for the remainder of 2008 requires caution.”
Emeritus
Assisted-living centers
June 30 %
2nd QTR 2008 2007 CHG
Profit ($25,234) ($1,589) -1,488
Per share (0.65) (0.08) -713
Revenue 186,928 108,067 +73.0
1st HALF 2008 2007 CHG
Profit ($51,202) ($11,324) -352.2
Per share (1.31) (0.61) -115
Revenue 372,824 215,765 +72.8
COMMENT: Higher operating costs and lease expenses led to a deeper quarterly loss for the Seattle-based operator of nursing homes and assisted-living centers. Average occupancy during the quarter slipped to 86.4 percent, from 87.2 percent in the first quarter; however, occupancy had rebounded to 87.8 percent by the end of the quarter.
Jones Soda
Beverage
June 30 %
2nd QTR 2008 2007 CHG
Profit ($2,733) $41
Per share (0.10) 0
Sales 14,012 13,262 +5.7
1st HALF 2008 2007 CHG
Profit ($6,586) $99
Per share (0.25) 0
Sales 24,366 22,537 +8.1
COMMENT: It’s the fourth straight quarterly loss for the Seattle company, whose CEO said in May it would “report modest losses for the next few quarters.” The company lost 3 cents more per share than analysts expected this quarter, according to Thomson Financial. Jones cut some upper-level sales staff during the quarter, which more than offset the cost of hiring nearly 30 people to oversee the way its products are merchandised in grocery stores.
Oncothyreon
Biotechnology
June 30 %
2nd QTR 2008 2007 CHG
Profit ($4,916) ($4,961) +0.9
Per share (0.25) (0.25) 0
Revenue 1,152 590 +95.3
1st HALF 2008 2007 CHG
Profit ($10,030) ($9,637) -4.1
Per share (0.51) (0.49) -4.1
Sales 3,172 761 +317
COMMENT: The Bellevue company saw its revenue nearly double from the same period last year, on increased sales of clinical material to Merck.
Trubion Pharmaceuticals
Biotechnology
June 30 %
2nd QTR 2008 2007 CHG
Profit ($6,632) ($7,455) +11.0
Per share (0.37) (0.42) +11.9
Revenues 4,468 4,980 -10.3
1st HALF 2008 2007 CHG
Profit ($12,600) ($12,474) -1.0
Per share (0.71) (0.71) 0
Revenues 8,431 9,815 -14.1
COMMENT: The Seattle company’s losses narrowed due to lower manufacturing costs, supply costs and licensing fees. The company expects 2008 revenue to be in the $15-million-to-$20-million range through the company’s research partnership with Wyeth.